The following study has recently been activated for patient enrollment by The University of Illinois Cancer Center Clinical Trials Office (CTO). Clink on the link to learn about the details regarding the study on clinicaltrials.gov.
For more information or questions about a study, email email@example.com or call 312-355-5112.
NRG-CC008: A Non-Randomized Prospective Clinical Trial Comparing the Non-Inferiority of Salpingectomy to Salpingo-Oophorectomy to Reduce the Risk of Ovarian Cancer Among BRCA1 Carriers [SOROCk]
Sponsor: NRG Oncology
Collaborator: National Cancer Institute
Principal Investigator: Shannon MacLaughlan, MD